BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24569973)

  • 1. [Social determinants of dropout from diagnosis and treatment by women with abnormal Pap smears in Buenos Aires, Argentina].
    Paolino M; Sankaranarayanan R; Arrossi S
    Rev Panam Salud Publica; 2013 Dec; 34(6):437-45. PubMed ID: 24569973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [How does type of health insurance affect receipt of Pap testing in Peru?].
    Barrionuevo-Rosas L; Palència L; Borrell C
    Rev Panam Salud Publica; 2013 Dec; 34(6):393-400. PubMed ID: 24569967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic and regional inequalities of pap smear coverage.
    Manica ST; Drachler Mde L; Teixeira LB; Ferla AA; Gouveia HG; Anschau F; Oliveira DL
    Rev Gaucha Enferm; 2016 Mar; 37(1):e52287. PubMed ID: 26982680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the social gradients for Pap smears and mammograms in Argentina: evidence from the 2005 and 2009 National Risk Factor Surveys.
    De Maio FG; Linetzky B; Ferrante D
    Public Health; 2012 Oct; 126(10):821-6. PubMed ID: 23083845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's knowledge about cervical cancer, Pap smear and human papillomavirus and its relation to screening in Argentina.
    Paolino M; Arrossi S
    Women Health; 2011 Jan; 51(1):72-87. PubMed ID: 21391162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Pap test by a population group in Buenos Aires.
    Klimovsky E; Matos E
    Bull Pan Am Health Organ; 1996 Dec; 30(4):313-21. PubMed ID: 9041742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inequalities in Pap smear screening for cervical cancer in Brazil.
    Martínez-Mesa J; Werutsky G; Campani RB; Wehrmeister FC; Barrios CH
    Prev Med; 2013 Oct; 57(4):366-71. PubMed ID: 23827721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequate follow-up for abnormal Pap smears in an urban population.
    Peterson NB; Han J; Freund KM
    J Natl Med Assoc; 2003 Sep; 95(9):825-32. PubMed ID: 14527050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.
    AL-Hammadi FA; Al-Tahri F; Al-Ali A; Nair SC; Abdulrahman M
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3379-3387. PubMed ID: 29286607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pap smear rates among Haitian immigrant women in eastern Massachusetts.
    Green EH; Freund KM; Posner MA; David MM
    Public Health Rep; 2005; 120(2):133-9. PubMed ID: 15842114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving follow-up after an abnormal Pap smear: a randomized controlled trial.
    Paskett ED; White E; Carter WB; Chu J
    Prev Med; 1990 Nov; 19(6):630-41. PubMed ID: 2263574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informational needs and the experiences of women with abnormal Papanicolaou smears.
    Bertram CC; Magnussen L
    J Am Acad Nurse Pract; 2008 Sep; 20(9):455-62. PubMed ID: 18786022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Reform, Medicaid Expansions, and Women's Cancer Screening.
    Ku L; Bysshe T; Steinmetz E; Bruen BK
    Womens Health Issues; 2016; 26(3):256-61. PubMed ID: 26926159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast and cervical cancer screening in obese minority women.
    Ferrante JM; Chen PH; Jacobs A
    J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving adherence to abnormal Pap smear follow-up.
    Abercrombie PD
    J Obstet Gynecol Neonatal Nurs; 2001; 30(1):80-8. PubMed ID: 11277165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
    Nuño T; Castle PE; Harris R; Estrada A; García F;
    J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perception and use of Pap smear screening among rural and urban women in Romania.
    Grigore M; Popovici R; Pristavu A; Grigore AM; Matei M; Gafitanu D
    Eur J Public Health; 2017 Dec; 27(6):1084-1088. PubMed ID: 29020396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.